Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 8/20 | 0.46 |
| ▸ | ESR1 | P03372 | 7/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.45 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.45 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | MPL | P40238 | 1/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CDK4 | P11802 | 1/20 | 0.36 |
| ▸ | CCND1 | P24385 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23861408 | 0.89 | ERN1 (0.44) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL23861481 | 0.88 | ESR1 (0.41) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL23861442 | 0.84 | ESR2 (0.49) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL23861627 | 0.82 | PTPN22 (0.50) | CYP1A2CYP2D6CYP2C9CYP2C19MEN1 | |
| SCHEMBL23861480 | 0.81 | CYP1A2 (0.35) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL23861405 | 0.78 | MEN1 (0.43) | MPLMEN1NPC1RAB9AKMT2A | |
| SCHEMBL23082053 | 0.76 | ESR1 (0.54) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL19063578 | 0.75 | HSD17B1 (0.56) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL23861459 | 0.75 | CYP2C9 (0.44) | ESR2ESR1CYP1A2HSD17B1HSD17B2 | |
| SCHEMBL23861565 | 0.75 | ESR1 (0.40) | ESR2ESR1CYP1A2HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11130724-B2 | Compound, resin, composition, resist pattern formation method, and circuit pattern formation method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11130724-B2 | Compound, resin, composition, resist pattern formation method, and circuit pattern formation method | RER1, NBAS, INTS9 | ESR2 1033/4885ESR1 713/4885CYP1A2 2085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.